Ligand Pharmaceuticals Inc(LGND)
65.08
Change: -2.18 (▼ -3.35%)
As of Tue 12/20/2022 11:03 AM% Of Value
Growth
Value Per Share
:
:
:
1210.14
48.66
24.5700 (as of 19/12/2022)
Fundamentals Data
| Open | 63.51 | Dividend | 21 |
| Close Price | 65.08 | DivYield | 0 % |
| High | 66.72 | Growth | 90.7 M |
| Low | 62.93 | Growth% | 48.66 |
| P/e | 17.701 | Volume | 396,925.0 |
| P/b | 10.6 | Market Capital | 1.0 B |
| Highest High | Lowest Low | ||
| 50 Days Moving Average | 76.93 (as of 21/12/2022) | 50 Days Moving Average Percentage | -18.214505224339 (as of 21/12/2022 |
| Industry: Major Pharmaceuticals |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 / 2017 | Year2 / 2018 | Year3 / 2019 | Year4 / 2020 | Current Year / 2021 |
| Revenue | 141.1 M | 251.4 M | 120.2 M | 186.4 M | 277.1 M |
| Cap Spending | 4.8 M | -10.8 M | -2.5 M | -3.1 M | -8.2 M |
| Operating Expenses | 67.6 M | 81.3 M | -698.1 M | 130.1 M | 136.0 M |
| Operating Cash Flow | 68.0 M | 163.7 M | 807.0 M | 25.8 M | 78.8 M |
| Free Cash Flow | 98.4 M | 183.1 M | -31.8 M | 51.4 M | 70.5 M |
| Free Cash Flow Per Share | 4.682 | 8.657 | -1.679 | 3.181 | 4.241 |
| Total liabilities | 224.5 M | 636.2 M | 648.9 M | 456.4 M | 338.3 M |
| Total cash | 20.6 M | 117.1 M | 71.5 M | 47.6 M | 19.5 M |
| ROE% | 0.032 | 0.243 | 0.673 | -0.004 | 0.072 |
| Outstanding Shares | 21.2 M | 20.4 M | 16.5 M | 16.6 M | 16.8 M |
| P/E | 260.983 | 17.701 | 2.711 | -814.426 | 29.854 |
| P/S | 23.224 | 10.089 | 14.183 | 13.041 | 6.155 |
| Revenue USD | 141.1 M | 251.4 M | 120.2 M | 186.4 M | 277.1 M |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|